Piper Sandler analyst Jessica Tassan downgrades CareMax (NASDAQ:CMAX) from Overweight to Neutral and announces $2 price target.
Piper Sandler Downgrades CareMax to Neutral, Announces $2 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.